CD4 and neoplasm: To assess whether targeting this molecule could be of clinical interest, we next compared the transcriptomic signature induced by HP1α-deletion in murine CD4+ T cells to the transcriptome of tumor-infiltrating T lymphocytes (TILs) isolated from patients with advanced melanoma28.